Home / Going-concern warnings / Traws Pharma, Inc.
Filed 2026-04-15 路 Form 10-K 路 Accession 0001104659-26-043832 nano
Price before filing: $1.59 (2026-04-14 close, split/dividend-adjusted)
Market cap at flag: $13.1M (2026-04-15) 路 Latest: $3.9M (2026-10-16)
| Window | TRAW | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | +18.2% | +6.4% | +11.8% | 2026-05-15 |
| 90 days | -55.7% | +8.5% | -64.2% | 2026-07-14 |
| 180 days | -73.8% | +12.6% | -86.4% | 2026-10-12 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: no open-market insider sales or purchases reported.
30 days after: 1 insider bought $998K (1 purchase)
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2026-04-15: red flag filed | |||||||
| 2026-04-16 | ORBIMED ADVISORS LLC (+1 joint filer) 10% owner | Purchase | 597,729 | $1.67 | $998K | no | Form 4 |
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2026-01-15 to 2026-05-15. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
"As discussed in Note 1 to the consolidated financial statements, the Company has incurred recurring losses from operations since inception that raise substantial doubt about its ability to continue as a going concern."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Going-concern opinion issued by: KPMG LLP
Source: independent auditor report in Form 10-K (period 2025-12-31)
Why this score: in auditor's report
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.